BRPI0414237A - formulações e métodos para o tratamento de cancer de mama com morinda citrifolia e metilsulfonilmetano - Google Patents

formulações e métodos para o tratamento de cancer de mama com morinda citrifolia e metilsulfonilmetano

Info

Publication number
BRPI0414237A
BRPI0414237A BRPI0414237-3A BRPI0414237A BRPI0414237A BR PI0414237 A BRPI0414237 A BR PI0414237A BR PI0414237 A BRPI0414237 A BR PI0414237A BR PI0414237 A BRPI0414237 A BR PI0414237A
Authority
BR
Brazil
Prior art keywords
breast cancer
formulations
treatment
methods
methylsulfonylmethane
Prior art date
Application number
BRPI0414237-3A
Other languages
English (en)
Inventor
Claude Jarakae Jensen
Mian Ying Wang
Chen Su
Stephen Story
Original Assignee
Morinda Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morinda Inc filed Critical Morinda Inc
Publication of BRPI0414237A publication Critical patent/BRPI0414237A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A61K36/746—Morinda
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

"FORMULAçõES E MéTODOS PARA O TRATAMENTO DE CáNCER DE MAMA COM MORINDA CITRIFOLIA E METILSULFONILMETANO". A presente invenção se refere a um avanço com relação às técnicas, formulações e métodos do estado da técnica para o tratamento de câncer de mama durante as suas fases iniciais, assim como a prevenção de câncer de mama, ao proporcionar uma formulação nutracêutica, segura que compreende Morinda citrifolia, metilsulfonilmetano (MSM), e outros ingredientes.
BRPI0414237-3A 2003-09-10 2004-09-10 formulações e métodos para o tratamento de cancer de mama com morinda citrifolia e metilsulfonilmetano BRPI0414237A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50172803P 2003-09-10 2003-09-10
US10/937,419 US20050118291A1 (en) 2003-09-10 2004-09-09 Formulations and methods for treating breast cancer with Morinda citrifolia and methylsulfonymethane
PCT/US2004/029896 WO2005025410A2 (en) 2003-09-10 2004-09-10 Formulations and methods for treating breast cancer with morinda citrifolia and methylsulfonymethane

Publications (1)

Publication Number Publication Date
BRPI0414237A true BRPI0414237A (pt) 2006-10-31

Family

ID=34316493

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0414237-3A BRPI0414237A (pt) 2003-09-10 2004-09-10 formulações e métodos para o tratamento de cancer de mama com morinda citrifolia e metilsulfonilmetano

Country Status (8)

Country Link
US (1) US20050118291A1 (pt)
EP (1) EP1662965A4 (pt)
JP (1) JP2007505146A (pt)
AU (1) AU2004272108B2 (pt)
BR (1) BRPI0414237A (pt)
CA (1) CA2538073A1 (pt)
RU (1) RU2330678C2 (pt)
WO (1) WO2005025410A2 (pt)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110217394A1 (en) * 2000-12-05 2011-09-08 Brett Justin West Iridoid Based Formulations
US20040192761A1 (en) * 2003-03-25 2004-09-30 Palu Afa Kehaati Preventative and treatment effects of morinda citrifolia as an aromatase inhibitor
US8574642B2 (en) 2000-12-05 2013-11-05 Tahitian Noni International, Inc. Antiviral Morinda citrifolia L. based formulations and methods of administration
US8652546B2 (en) 2007-09-06 2014-02-18 Tahitian Noni International, Inc. Morinda citrifolia based formulations for regulating T cell immunomodulation in neonatal stock animals
US20110171333A1 (en) * 2000-12-05 2011-07-14 Bryant Wadsworth Morinda Citrifolia Based Antioxidant and Antimicrobial Formulations for Improved Color Stability and Increased Shelf Life of Various Meat Products
US6855345B2 (en) * 2001-11-02 2005-02-15 Morinda, Inc. Preventative and treatment effects of Morinda citrifolia on diabetes and its related conditions
US8790727B2 (en) * 2000-12-05 2014-07-29 Tahitian Noni International, Inc. Morinda citrifolia and iridoid based formulations
US20050181082A1 (en) * 2002-05-21 2005-08-18 Fumiyuki Isami Morinda citrifolla based antifungal formulations and methods
US7442395B2 (en) * 2002-11-14 2008-10-28 Tahitian Noni International, Inc. Formulation for treating candidiasis using Morinda citrifolia
US20110160057A1 (en) * 2001-11-14 2011-06-30 Bryant Wadsworth Morinda Citrifolia Based Antimicrobial Formulations
JP4073826B2 (ja) * 2003-06-04 2008-04-09 タヒチアン ノニ インターナショナル インコーポレーテッド ヤエヤマアオキの抽出物を含む農業用活力剤
US20070259060A1 (en) * 2003-08-12 2007-11-08 Mian-Ying Wang Formulations and Methods for Treating Breast Cancer with Morinda Citrifolia and Methylsulfonymethane
US20060204601A1 (en) * 2005-03-09 2006-09-14 Palu Afa K Formulations and methods for preventing and treating substance abuse and addiction
US20060280818A1 (en) * 2005-05-26 2006-12-14 Palu Afa K Nicotinic acetylcholine receptor antagonist
US20070122507A1 (en) * 2005-05-26 2007-05-31 Palu Afa K Histone deacetylase and tumor necrosis factor converting enzyme inhibition
US20070184137A1 (en) * 2005-11-29 2007-08-09 Palu Afa K Morinda Citrifolia L. Based Formulations for Inhibiting Matrix Metalloproteinase Enzymes
US20070154579A1 (en) * 2005-11-29 2007-07-05 Palu Afa K Morinda Citrifolia Based Formulation And Methods For Weight Management
US20070166417A1 (en) * 2005-11-29 2007-07-19 Palu Afa K Formulation and Methods for Use of Morinda Citrifolia Seed Oil
US20070281903A1 (en) * 2006-05-04 2007-12-06 Palu Afa K Morinda Citrifolia-Based Formulation 5-LOX And 15-LOX
US8025910B2 (en) 2006-05-12 2011-09-27 Tahitian Noni International, Inc. Method and composition for administering bioactive compounds derived from Morinda citrifolia
US8535741B2 (en) 2006-05-12 2013-09-17 Morinda, Inc. Method and composition for administering bioactive compounds derived from Morinda citrifolia
US20080206368A1 (en) * 2007-02-26 2008-08-28 Mian-Ying Wang Administration of Morinda Citrifolia L. Based Formulations to Increase Birth Rates
US20080317890A1 (en) * 2007-06-21 2008-12-25 Claude Jarakae Jensen Method for treating visual impairment through the prophylactic administration of a morinda citrifolia-based naturaceutical
US20090196944A1 (en) * 2008-02-01 2009-08-06 Brad Rawson Methods of Manufacture of Morinda Citrifolia Based Compositions for Treatment of Anti-Inflammatory Diseases through Inhibition of Cox-1, Cox-2, Interleukin -1beta, Interleukin-6, TNF-alpha, HLE, and iNOS
ES2693687T3 (es) 2009-06-05 2018-12-13 Joan M. Caron Compuestos y composiciones para uso en el tratamiento del cáncer
AU2010313253B2 (en) 2009-10-30 2015-02-19 Abela Pharmaceuticals, Inc. Dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) formulations to treat osteoarthritis
WO2011053854A1 (en) 2009-10-30 2011-05-05 Biogenic Innovations, Llc Use of methylsulfonylmethane (msm) to modulate microbial activity
US20110206786A1 (en) * 2010-02-23 2011-08-25 Brett Justin West Acai and Iridoid Based Formulations
KR101342992B1 (ko) * 2011-11-09 2013-12-18 건국대학교 산학협력단 Ｍｓｍ을 유효성분으로 포함하는 암 질환 예방 및 치료용 조성물
CN114010629A (zh) 2014-01-06 2022-02-08 英国神盾Tx股份有限公司 三麦芽酚铁的剂量方案
GB201418710D0 (en) 2014-10-21 2014-12-03 Iron Therapeutics Holdings Ag Dosage regimen
CN104623566A (zh) * 2015-03-16 2015-05-20 徐若曾 治疗乳腺癌的清热解毒剂及制法
TWI884912B (zh) 2018-02-15 2025-06-01 生華生物科技股份有限公司 喹啉酮類似物及其鹽、組合物及其使用方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5071878A (en) * 1979-08-30 1991-12-10 Herschler R J Use of methylsulfonylmethane to enhance diet of an animal
FI91859C (fi) * 1987-06-17 1994-08-25 Eisai Co Ltd Analogiamenetelmä antiallergisena aineena aktiivisen bentsotiatsolijohdannaisen valmistamiseksi
US5595756A (en) * 1993-12-22 1997-01-21 Inex Pharmaceuticals Corporation Liposomal compositions for enhanced retention of bioactive agents
US6428816B1 (en) * 1994-04-08 2002-08-06 Cognis Australia Pty., Ltd. Carotenoid agent for inhibiting the conversion of epithelial cells to tumors
US6429204B1 (en) * 1997-01-15 2002-08-06 University Of Miami Method of inhibiting cancer growth
US6254913B1 (en) * 1999-08-27 2001-07-03 Morinda, Inc. Morinda citrifolia dietary fiber and method
JP2005511479A (ja) * 2001-04-17 2005-04-28 モリンダ・インコーポレーテッド モリンダシトリフォリア油および果汁の緩和作用
US20030157205A1 (en) * 2001-12-31 2003-08-21 Jensen Claude Jarakae Inhibitory and preventative effects of processed morinda citrifolia on mutagenesis and carcinogenesis in mammals

Also Published As

Publication number Publication date
US20050118291A1 (en) 2005-06-02
WO2005025410A2 (en) 2005-03-24
AU2004272108A1 (en) 2005-03-24
WO2005025410A3 (en) 2005-12-22
EP1662965A2 (en) 2006-06-07
RU2330678C2 (ru) 2008-08-10
AU2004272108B2 (en) 2007-02-01
JP2007505146A (ja) 2007-03-08
CA2538073A1 (en) 2005-03-24
EP1662965A4 (en) 2006-10-25
RU2006111460A (ru) 2007-10-27

Similar Documents

Publication Publication Date Title
Arumugam et al. Effect of various antioxidants on the shear bond strength of composite resin to bleached enamel: An: in vitro: study
WO2005025410A3 (en) Formulations and methods for treating breast cancer with morinda citrifolia and methylsulfonymethane
Keating et al. Antimetabolic effects of polyphenols in breast cancer cells: Focus on glucose uptake and metabolism
AR109246A2 (es) USO DE UN INMUNOCONJUGADO QUE COMPRENDE UN ANTICUERPO ANTI-ErbB2 PARA LA MANUFACTURA DE UN MEDICAMENTO
EP4223316A3 (en) Improved antibody-oligonucleotide conjugate
BR112014031914A2 (pt) cápsula de estradiol solúvel para inserção vaginal
DOP2006000057A (es) Composición farmaceútica para el tratamiento del cáncer
MX339658B (es) Combinaciones y metodos para administracion subcutanea de inmunoglobulina y hialuronidasa.
UY37952A (es) Formulaciones de un inhibidor de la quinasa trk macrocíclica
CL2008003582A1 (es) Uso de una composicion farmaceutica que contiene cisteamina o cistamina en la preparacion de un medicamento util para el tratamiento de una enfermedad de higado graso no alcholico (nafld) o esteatohepatitis no alcoholica (nash).
NZ600039A (en) Biocompatible biodegradable fumagillin analog conjugates
NZ589228A (en) Combination of tetrahydrocannabinol (THC) and cannabidiol (CBD) for the treatment of a brain tumour
WO2005067489A3 (en) Type ii diabetes
BRPI0907970A8 (pt) composição para tratamento dos cabelos ou pelos e método para aumentar o diâmetro dos cabelos ou pelos
AR047928A1 (es) Derivados de tetrahidropiridoindol
EA201001283A1 (ru) Комбинация витамина d и 25-гидроксивитамина d3
NO20075540L (no) Lignian-inneholdende sammensetninger
BRPI0806863B8 (pt) uso de um éster de forbol na preparação de um medicamento para prevenção ou tratamento de uma infecção por hiv
UY30215A1 (es) Derivados de cromanol sustituidos, procedimientos para su preparacion, composiciones farmacéuticas que los contienen y aplicaciones
MX2022015799A (es) Composicion y metodo para el tratamiento del dolor cronico.
CL2004000899A1 (es) Composicion farmaceutica que contiene la sal sodica de telmisartan y un agente diuretico y procedimiento de preparacion.
BR0109672A (pt) Uso de zd6126 ou de um seu sal farmaceuticamente aceitável e um de: um agente antitumoral de plantina e um taxano, composição farmacêutica, produto de combinação, kit, e, método para a produção de um efeito de danificação vascular em um animal de sangue quente
BR112022021640A2 (pt) Usos e formulações de canabinoides
MX2018002533A (es) Composicion sinergica para el mantenimiento de un equilibrio saludable de la microflora.
ES2195939T3 (es) Composicion para prevencion y/o tratamiento de trastornos circulatorios que comprende derivados de l-carnitina y extractos de ginkgo biloba.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A E 7A ANUIDADE(S)

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011.

B15K Others concerning applications: alteration of classification

Ipc: A61K 31/10 (2006.01), A23L 33/10 (2016.01), A23L 3